• 1
    Wallot MA, Mathot M, Janssen M, et al. Long-term survival and late graft loss in pediatric liver transplant recipients—A 15-year single-center experience. Liver Transpl 2002; 8: 615622.
  • 2
    Ng VL, Fecteau A, Shepherd R, et al. Outcomes of 5-year survivors of pediatric liver transplantation: Report on 461 children from a north american multicenter registry. Pediatrics 2008; 122: e1128–e1135.
  • 3
    Calne RY, Rolles K, White DJ, et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979; 2: 10331036.
  • 4
    Calne RY, Rolles K, White DJ, et al. Cyclosporin A in clinical kidney grafting from cadaver donors. Proc Eur Dial Transplant Assoc 1979; 16: 305309.
  • 5
    White DJ, Calne RY, Plumb A. Mode of action of cyclosporin A: A new immunosuppressive agent. Transplant Proc 1979; 11: 855859.
  • 6
    Zimmermann FA, White DJ, Gokel JM, Calne RY. Orthotopic liver transplantation in rats. Prolonging of survival time of allotransplants using cyclosporin A in an acute rejection model. Chir Forum Exp Klin Forsch 1979; 339344.
  • 7
    Mells G, Neuberger J. Reducing the risks of cardiovascular disease in liver allograft recipients. Transplantation 2007; 83: 11411150.
  • 8
    Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. In: Proceedings of an International Expert Panel Meeting. 19 February 2003; Barcelona, Spain. Transplantation 2003; 75 (Suppl): SS3SS24.
  • 9
    Reuben A. Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity. Liver Transpl 2001; 7 (Suppl 1): S13S21.
  • 10
    Ader JL, Rostaing L. Cyclosporin nephrotoxicity: Pathophysiology and comparison with FK-506. Curr Opin Nephrol Hypertens 1998; 7: 539545.
  • 11
    Kobashigawa JA, Kasiske BL. Hyperlipidemia in solid organ transplantation. Transplantation 1997; 63: 331338.
  • 12
    Textor SC, Taler SJ, Canzanello VJ, Schwartz L, Augustine JE. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl 2000; 6: 521530.
  • 13
    Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901906.
  • 14
    McDiarmid SV, Gornbein JA, Fortunat M, et al. Serum lipid abnormalities in pediatric liver transplant patients. Transplantation 1992; 53: 109105.
  • 15
    Smith JM, Nemeth TL, McDonald RA. Current immunosuppressive agents in pediatric renal transplantation: Efficacy, side-effects and utilization. Pediatr Transplant 2004; 8: 445453.
  • 16
    Lauer RM, Clarke WR. Childhood risk factors for high adult blood pressure: The Muscatine Study. Pediatrics 1989; 84: 633641.
  • 17
    McNiece KL, Poffenbarger TS, Turner JL, et al. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr 2007; 150: 640644, 644 e1.
  • 18
    Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97: 19071911.
  • 19
    Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa heart study. N Engl J Med 1998; 338: 16501656.
  • 20
    Harambat J, Ranchin B, Dubourg L, et al. Renal function in pediatric liver transplantation: A long-term follow-up study. Transplantation 2008; 86: 10281034.
  • 21
    Canzanello VJ, Textor SC, Taler SJ, et al. Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK 506). Liver Transpl Surg 1998; 4: 328334.
  • 22
    System URD USRDS 2004; Annual Data Report. 2004.
  • 23
    The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (Suppl) 4th Report: 555576.
  • 24
    Ostchega Y, Carroll M, Prineas RJ, et al. Trends of elevated blood pressure among children and adolescents: Data from the national health and nutrition examination survey1988–2006. Am J Hypertens 2009; 22: 5967.
  • 25
    Rodriguez BL, Liese DD, Fujimoto AD, et al. Imperatore G, for the SEARCH study group Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: The search for diabetes in youth study. J Pediatr 2010; 157: 245–251.
  • 26
    Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571590.
  • 27
    Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000 314: 127.
  • 28
    Staples A, Wong C. Risk factors for progression of chronic kidney disease. Curr Opin Pediatr 2010; 22: 161169.
  • 29
    Locatelli F, Marcelli D, Comelli M, et al. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern italian cooperative study group. Nephrol Dial Transplant 1996; 11: 461467.
  • 30
    Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 1328.
  • 31
    Mitsnefes M, Ho PL, McEnery PT. Hypertension and progression of chronic renal insufficiency in children: A report of the north american pediatric renal transplant cooperative study (NAPRTCS). J Am Soc Nephrol 2003; 14: 26182622.
  • 32
    Wingen AM, Fabian-Bach C, Schaefer F, Mehis O. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European study group of nutritional treatment of chronic renal failure in childhood. Lancet 1997; 349: 11171123.
  • 33
    Portman RJ, McNiece KL, Swinford RD, Braun MC, Samuels JA. Pediatric hypertension: Diagnosis, evaluation, management, and treatment for the primary care physician. Curr Probl Pediatr Adolesc Health Care 2005; 35: 262294.
  • 34
    Simonetti GD, Rizzi M, Bianchetti MG. Simple references for managing arterial hypertension in children with kidney disease. J Hypertens 28: 1109 [author reply 1109–10].
  • 35
    Lurbe E, Cifkova R, Cruickshank JK, et al. Management of high blood pressure in children and adolescents: Recommendations of the european society of hypertension. J Hypertens 2009; 27: 17191742.
  • 36
    Wuhl E, Trivelli A, Picca S, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 16391650.